Livia Fucci
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Journal: Journal of translational medicine
Published: October 02, 2025
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience.
Journal: Frontiers in medicine
Published: October 14, 2024
The molecular tumor board as a step in cancer patient management: a southern Italian experience.
Journal: Frontiers in medicine
Published: May 14, 2024
An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patients.
Journal: Journal of translational medicine
Published: March 07, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
Journal: Frontiers in immunology
Published: January 12, 2024
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 16, 2023
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy.
Journal: Pharmacological research
Published: March 21, 2022
A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Impressive Tumoral Response and Death due to Legionella pneumophila Infection: A Unique Case Report.
Journal: Frontiers in oncology
Published: February 16, 2022
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study.
Journal: Expert opinion on therapeutic targets
Published: November 30, 2021
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells.
Journal: Oncology research
Published: July 28, 2021
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp.
Journal: Frontiers in oncology
Published: July 16, 2021
Last Updated: 09/26/2026